BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 23992923)

  • 1. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
    Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
    Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
    Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
    Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS.
    Michaelovsky E; Gothelf D; Korostishevsky M; Frisch A; Burg M; Carmel M; Steinberg T; Inbar D; Apter A; Weizman A
    Int J Neuropsychopharmacol; 2008 May; 11(3):351-63. PubMed ID: 17949513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome.
    Glaser B; Debbane M; Hinard C; Morris MA; Dahoun SP; Antonarakis SE; Eliez S
    Am J Psychiatry; 2006 Mar; 163(3):537-9. PubMed ID: 16513880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome.
    Gothelf D; Hoeft F; Ueno T; Sugiura L; Lee AD; Thompson P; Reiss AL
    J Psychiatr Res; 2011 Mar; 45(3):322-31. PubMed ID: 20817203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
    Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
    J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IQ and hemizygosity for the Val
    Franconi CP; McDonald-McGinn D; Zackai EH; McNamara MA; Salmons H; Moss E; Gur RE; Devoto M; Emanuel BS
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1112-1115. PubMed ID: 27619075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a functional COMT polymorphism on brain anatomy and cognitive function in adults with velo-cardio-facial syndrome.
    van Amelsvoort T; Zinkstok J; Figee M; Daly E; Morris R; Owen MJ; Murphy KC; De Haan L; Linszen DH; Glaser B; Murphy DG
    Psychol Med; 2008 Jan; 38(1):89-100. PubMed ID: 17493297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COMT and anxiety and cognition in children with chromosome 22q11.2 deletion syndrome.
    Shashi V; Howard TD; Keshavan MS; Kaczorowski J; Berry MN; Schoch K; Spence EJ; Kwapil TR
    Psychiatry Res; 2010 Jul; 178(2):433-6. PubMed ID: 20488547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome.
    Takarae Y; Schmidt L; Tassone F; Simon TJ
    Cogn Affect Behav Neurosci; 2009 Mar; 9(1):83-90. PubMed ID: 19246329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
    Basel D; Mosheva M; Maeder J; Schneider M; Shani S; Weinberger R; Eliez S; Gothelf D
    Eur Child Adolesc Psychiatry; 2022 Sep; 31(9):1367-1375. PubMed ID: 33871687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome.
    Bearden CE; Jawad AF; Lynch DR; Sokol S; Kanes SJ; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
    Am J Psychiatry; 2004 Sep; 161(9):1700-2. PubMed ID: 15337663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome.
    Gothelf D; Hoeft F; Hinard C; Hallmayer JF; Stoecker JV; Antonarakis SE; Morris MA; Reiss AL
    Hum Brain Mapp; 2007 Jun; 28(6):533-42. PubMed ID: 17427209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis.
    Perlstein MD; Chohan MR; Coman IL; Antshel KM; Fremont WP; Gnirke MH; Kikinis Z; Middleton FA; Radoeva PD; Shenton ME; Kates WR
    Schizophr Res; 2014 Jan; 152(1):117-23. PubMed ID: 24321711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.
    Borroni B; Grassi M; Costanzi C; Zanetti M; Archetti S; Franzoni S; Caimi L; Padovani A
    Neurobiol Aging; 2007 Aug; 28(8):1231-8. PubMed ID: 16837108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A COMT gene haplotype associated with methamphetamine abuse.
    Jugurnauth SK; Chen CK; Barnes MR; Li T; Lin SK; Liu HC; Collier DA; Breen G
    Pharmacogenet Genomics; 2011 Nov; 21(11):731-40. PubMed ID: 21934638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.